Literature DB >> 23045968

Prothymosin α plays multifunctional cell robustness roles in genomic, epigenetic, and nongenomic mechanisms.

Hiroshi Ueda1, Hayato Matsunaga, Sebok Kumar Halder.   

Abstract

Prothymosin α (ProTα) possesses multiple functions for cell robustness. This protein functions intracellularly to stimulate cell proliferation and differentiation through epigenetic or genomic mechanisms. ProTα also regulates the cell defensive mechanisms through an interaction with the Nrf2-Keap1 system. Under the apoptotic conditions, it inhibits apoptosome formation by binding to Apaf-1. Regarding extracellular functions, ProTα is extracellularly released from the nucleus upon necrosis-inducing ischemia stress in a manner of nonclassical release, and thereby inhibits necrosis. However, under the condition of apoptosis, the C-terminus of ProTα is cleaved off and loses binding activity to cargo protein S100A13 for nonclassical release. However, cleaved ProTα is retained in the cytosol and inhibits apoptosome formation. ProTα was recently reported to cause immunological actions through the Toll-like receptor 4. However, the authors also suggest the possible existence of additional receptors for robust cell activities against ischemia stress.
© 2012 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23045968     DOI: 10.1111/j.1749-6632.2012.06675.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  8 in total

1.  Prothymosin α variants isolated from CD8+ T cells and cervicovaginal fluid suppress HIV-1 replication through type I interferon induction.

Authors:  Avelino Teixeira; Benjamin Yen; Gabriele Luca Gusella; Albert G Thomas; Michael P Mullen; Judith Aberg; Xintong Chen; Yujin Hoshida; Harm van Bakel; Eric Schadt; Christopher F Basler; Adolfo García-Sastre; Arevik Mosoian
Journal:  J Infect Dis       Date:  2014-11-17       Impact factor: 5.226

2.  Hexapeptide derived from prothymosin alpha attenuates cisplatin-induced acute kidney injury.

Authors:  Kenta Torigoe; Yoko Obata; Miki Torigoe; Satoru Oka; Kazuo Yamamoto; Takehiko Koji; Hiroshi Ueda; Hiroshi Mukae; Tomoya Nishino
Journal:  Clin Exp Nephrol       Date:  2020-01-07       Impact factor: 2.801

3.  Involvement of SNARE Protein Interaction for Non-classical Release of DAMPs/Alarmins Proteins, Prothymosin Alpha and S100A13.

Authors:  Hayato Matsunaga; Sebok Kumar Halder; Hiroshi Ueda
Journal:  Cell Mol Neurobiol       Date:  2020-08-27       Impact factor: 5.046

4.  Zn2+-binding in the glutamate-rich region of the intrinsically disordered protein prothymosin-alpha.

Authors:  Sriramya Garapati; William Monteith; Chris Wilson; Anastasiia Kostenko; John M Kenney; Allison S Danell; Colin S Burns
Journal:  J Biol Inorg Chem       Date:  2018-09-05       Impact factor: 3.358

5.  Critical Functionality Effects from Storage Temperature on Human Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium Cell Suspensions.

Authors:  Shohei Kitahata; Yuji Tanaka; Kanji Hori; Cody Kime; Sunao Sugita; Hiroshi Ueda; Masayo Takahashi
Journal:  Sci Rep       Date:  2019-02-27       Impact factor: 4.379

Review 6.  Thymosins in multiple sclerosis and its experimental models: moving from basic to clinical application.

Authors:  Martina Severa; Jing Zhang; Elena Giacomini; Fabiana Rizzo; Marilena Paola Etna; Melania Cruciani; Enrico Garaci; Michael Chopp; Eliana Marina Coccia
Journal:  Mult Scler Relat Disord       Date:  2018-10-02       Impact factor: 4.339

7.  Prothymosin α overexpression contributes to the development of pulmonary emphysema.

Authors:  Bing-Hua Su; Yau-Lin Tseng; Gia-Shing Shieh; Yi-Cheng Chen; Ya-Chieh Shiang; Pensee Wu; Kuo-Jung Li; Te-Hsin Yen; Ai-Li Shiau; Chao-Liang Wu
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

8.  Subcellular dissemination of prothymosin alpha at normal physiology: immunohistochemical vis-a-vis western blotting perspective.

Authors:  Caroline Mwendwa Kijogi; Christopher Khayeka-Wandabwa; Keita Sasaki; Yoshimasa Tanaka; Hiroshi Kurosu; Hayato Matsunaga; Hiroshi Ueda
Journal:  BMC Physiol       Date:  2016-03-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.